Abdominal subcutaneous fat thickness and homeostasis model assessment of insulin resistance as simple predictors of nonalcoholic steatohepatitis

References

• The GBD 2015 Obesity Collaborators, Afshin A , Forouzanfar MH , Reitsma MB, Sur P, Estep K, et al. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med . 2017;377(1):13–27. doi:10.1056/NEJMoa1614362 28604169
   PubMed Web of Science ®Google Scholar
• Lauby-Secretan B , Scoccianti C , Loomis D , Grosse Y , Bianchini F , Straif K . Body fatness and cancer — viewpoint of the IARC working group. N Engl J Med . 2016;375:794–798. doi:10.1056/NEJMsr1606602 27557308
   PubMed Web of Science ®Google Scholar
• Angulo P . Nonalcoholic fatty liver disease. N Engl J Med . 2002;346:1221–1231. doi:10.1056/NEJMra011775 11961152
   PubMed Web of Science ®Google Scholar
• Jessica B , Michele D , Brent AN , et al. Clinical model for NASH and advanced fibrosis in adult patients with diabetes and NAFLD: guidelines for referral in NAFLD. Diabetes Care . 2015;38:1347–1355. doi:10.2337/dc14-1239 25887357
   PubMed Web of Science ®Google Scholar
• Petäjä EM , Yki-Järvinen H . Definitions of normal liver fat and the association of insulin sensitivity with acquired and genetic NAFLD-a systematic review. Int J Mol Sci . 2016;17:E633. doi:10.3390/ijms17050633 27128911
   PubMed Web of Science ®Google Scholar
• Younossi ZM , Koenig AB , Abdelatif D , Fazel Y , Henry L , Wymer M . Epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology . 2016;64:73–84. doi:10.1002/hep.28431 26707365
   PubMed Web of Science ®Google Scholar
• Kahal H , Abouda G , Rigby AS , Coady AM , Kilpatrick ES , Atkin SL . Glucagon-like peptide-1 analogue, liraglutide, improves liver fibrosis markers in obese women with polycystic ovary syndrome and nonalcoholic fatty liver disease. Clin Endocrinol (Oxf) . 2014;81:523–528. doi:10.1111/cen.12369 24256515
   PubMed Web of Science ®Google Scholar
• Bayard M , Holt J , Boroughs E . Nonalcoholic fatty liver disease. Am Fam Physician . 2006;73:1961–1968.16770927
   PubMed Web of Science ®Google Scholar
• Bohte AE , van Werven JR , Bipat S , Stoker J . The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis. Eur Radiol . 2011;21:87–97. doi:10.1007/s00330-010-1905-5 20680289
   PubMed Web of Science ®Google Scholar
• Ducluzeau PH , Manchec-Poilblanc PM , Roullier V , et al. Distribution of abdominal adipose tissue as a predictor of hepatic steatosis assessed by MRI. Clin Radiol . 2010;65:695–700. doi:10.1016/j.crad.2010.03.013 20696296
   PubMed Web of Science ®Google Scholar
• Alkassabany YM , Farghaly AG , El-Ghitany E . Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt. Arab J Gastroenterol . 2014;15(2). doi:10.1016/j.ajg.2014.05.002
   Web of Science ®Google Scholar
• Zaki M , Ezzat W , Elhosary Y , Saleh O . Predictors of non-alcoholic fatty liver disease in Egyptian obese adolescents. Int Scholarly Sci Res Innovation . 2014;8(9):657–660.
   Google Scholar
• World Medical Association. World Medical Association Declaration of Helsinki ethical principles for medical research involving human subjects. Jama . 2013;310:2191–2194. doi:10.1001/jama.2013.281053 24141714
   PubMed Web of Science ®Google Scholar
• Mottin CC , Moretto M , Padoin AV , et al. The role of ultrasound in the diagnosis of hepatic steatosis in morbidly obese patients. Obes Surg . 2004;14:635–637. doi:10.1381/096089204323093408 15186630
   PubMed Web of Science ®Google Scholar
• Rumack CM . Diagnostic ultrasound In: Rumack CM , editor. General Adult Ultrasound St Louis: Mosby; 1998;110–112.
   Google Scholar
• Hegazy M , Mostafa A . Liver ultrasound scanning in the detection of hepatic steatosis and fibrosis in NASH patients. Egypt J Intern Med . 2012;24:27–31.
   Google Scholar
• Younossi ZM , Koenig AB , Abdelatif D , Fazel Y , Henry L , Wymer M . Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology . 2016;64:73–84. doi:10.1002/hep.28431 26707365
   PubMed Web of Science ®Google Scholar
• Hegazy M , Abdel Samie R , Ezzat A , Ramadan N , Rashed L , ElSayed A . PNPLA3 and TNF-α G238A genetic polymorphisms in Egyptian patients with different grades of severity of NAFLD. OJGas . 2016;6:53–64. doi:10.4236/ojgas.2016.63008
   Google Scholar
• Holterman AX , Guzman G , Fantuzzi G , et al. Nonalcoholic fatty liver disease in severely obese adolescent and adult patients. Obesity (Silver Spring) . 2013;21:591–597. doi:10.1002/oby.20174 23592668
   PubMed Web of Science ®Google Scholar
• Nuttall FQ . Body mass index: obesity, BMI, and health: a critical review. Nutr Today . 2015;50:117–128. doi:10.1097/NT.0000000000000092 27340299
   PubMedGoogle Scholar
• Wajchenberg BL . Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev . 2000;21:697–738. doi:10.1210/edrv.21.6.0415 11133069
   PubMed Web of Science ®Google Scholar
• Yano K , Hosokawa K , Nakai K , Kubo T , Matsuo Y . Regional differences in ultrasonic assessment of subcutaneous fat thickness in the abdomen: effects on the TRAM flap. Ann Plast Surg . 2003;51:130–135. doi:10.1097/01.SAP.0000058503.46432.96 12897514
   PubMed Web of Science ®Google Scholar
• Gaba RC , Knuttinen MG , Brodsky TR , et al. Hepatic steatosis: correlations of body mass index, CT fat measurements, and liver density with biopsy results. Diagn Interv Radiol . 2012;18:282–287. doi:10.4261/1305-3825.DIR.4958-11.2 22258794
   PubMed Web of Science ®Google Scholar
• Lee SH , Kim D , Baek MY , et al. Abdominal subcutaneous fat thickness measured by ultrasonography correlates with hyperlipidemia and steatohepatitis in obese children. Pediatr Gastroenterol Hepatol Nutr . 2015;18:108–114. doi:10.5223/pghn.2015.18.2.108 26157696
   PubMedGoogle Scholar
• Parente DB , Oliveira N , Brasil P , et al. Preperitoneal fat as a non-invasive marker of increased risk of severe non-alcoholic fatty liver disease in patients with type 2 diabetes. J Gastroenterol Hepatol . 2018;33(2):511–517. doi:10.1111/jgh.13903 28726335
   PubMed Web of Science ®Google Scholar
• van der Poorten D , Milner KL , Hui J , et al. Visceral fat: a key mediator of steatohepatitis in metabolic liver disease. Hepatology . 2008;48:449–457. doi:10.1002/hep.v48:2 18627003
   PubMed Web of Science ®Google Scholar
• Fukuda K , Seki Y , Ichihi M , et al. Usefulness of ultrasonographic estimation of preperitoneal and subcutaneous fat thickness in the diagnosis of nonalcoholic fatty liver disease in diabetic patients. J Med Ultrason . 2015;42:357–363. doi:10.1007/s10396-015-0615-7
   Web of Science ®Google Scholar
• Rader DJ . Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus. Am J Med . 2007;120:S12–S18. doi:10.1016/j.amjmed.2007.01.003
   PubMed Web of Science ®Google Scholar
• Geloneze B , Repetto EM , Geloneze SR , Tambascia MA , Ermetice MN . The threshold value for insulin resistance (HOMA-IR) in an admixture population. IR in the Brazilian metabolic syndrome study. Diabetes Res Clin Pract . 2006;13:219–220. doi:10.1016/j.diabres.2005.10.017
   Web of Science ®Google Scholar
• Summer AE , Cowie CC . Ethnic differences in the ability of triglyceride levels to identify insulin resistance. Atherosclerosis . 2008;13:696–703. doi:10.1016/j.atherosclerosis.2006.12.018
   Web of Science ®Google Scholar
• Hegazy M , Abdel-Rahman M , El-Gayar Dina AH . Liver ultrasound is more sensitive in assessing the severity of nonalcoholic fatty liver disease with homeostasis model assessment-insulin resistance. Eglj . 2012;12:41–46.
   Google Scholar
• Isaksen VT , Larsen MA , Goll R , Florholmen JR , Paulssen EJ . Hepatic steatosis, detected by hepatorenal index in ultrasonography, as a predictor of insulin resistance in obese subjects. BMC Obes . 2016;20(3):39. doi:10.1186/s40608-016-0118-0
   Google Scholar
• De Barros F , Setúbal S , Martinho JM , Ferraz L , Gaudêncio A . Correlation of non-alcoholic fatty liver disease and features of metabolic syndrome in morbidly obese patients in the preoperative assessment for bariatric surgery. Arq Bras Cir Dig . 2016;29:260–263. doi:10.1590/0102-6720201600040011 28076482
   PubMedGoogle Scholar
• Souza MR , Diniz Mde F , Medeiros-Filho JE , Araújo MS . Metabolic syndrome and risk factors for non-alcoholic fatty liver disease. Arq Gastroenterol . 2012;49:89–96. doi:10.1590/S0004-28032012000100015 22481692
   PubMedGoogle Scholar
• Gupte P , Amarapurkar D , Agal S , et al. Non-alcoholic steatohepatitis in type 2 diabetes mellitus. J Gastroenterol Hepatol . 2004;19:854–858. doi:10.1111/jgh.2004.19.issue-8 15242486
   PubMed Web of Science ®Google Scholar
• Ong JP , Elariny H , Collantes R , et al. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients. Obes Surg . 2005;15:310–315. doi:10.1381/0960892053576820 15826462
   PubMed Web of Science ®Google Scholar